Interactions of Alcuronium, TMB-8, and Other Allosteric Ligands with Muscarinic Acetylcholine Receptors: Studies with Chimeric Receptors
- 1 December 2000
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET)
- Vol. 58 (6), 1451-1460
- https://doi.org/10.1124/mol.58.6.1451
Abstract
A series of ligands that allosterically modulate the binding of classical ligands to muscarinic receptors was evaluated at wild-type and chimeric receptors. All of the ligands studied had highest affinity toward the M2 subtype and lowest affinity toward the M5 subtype. The chimeric receptors were mostly M5 sequence; the amount of M2 sequence ranged from about 6 to just under 30%. Alcuronium and TMB-8 had much higher affinity for the chimeric receptor that included the M2 second outer loop of the receptor plus flanking regions of TM4 and TM5 than for any of the other chimeric receptors (the affinities of which remained similar to that of the M5subtype). However, this chimera retained the negative cooperativity between alcuronium and the classical antagonistN-methylscopolamine that is characteristic of M5 (these ligands are positively cooperative at M2). Verapamil, tetrahydroaminoacridine, andd-tubocurarine were also sensitive to that chimeric substitution, although verapamil and tetrahydroaminoacridine had even higher affinity for a chimera with M2 sequence in TM7. None of these ligands shared gallamine9s sensitivity to a region of the third outer loop, but studies in which obidoxime reversed the allosteric effects of gallamine and other ligands suggested that they nevertheless compete for a common site. In summary, although the present data are consistent with previous studies that have suggested that allosteric ligands bind to the outermost regions of muscarinic receptors, it appears that different allosteric ligands may derive subtype selectivity from different regions of the receptor.Keywords
This publication has 16 references indexed in Scilit:
- Competitive and allosteric interactions of 6-chloro-5,10-dihydro-5-[(1-methyl-4-piperidinyl)acetyl]-11h-dibenzo[b,e][1, 4]diazepine-11-one hydrochloride (UH-AH 37) at muscarinic receptors, via distinct epitopesBiochemical Pharmacology, 1999
- Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypesLife Sciences, 1997
- Two-point kinetic experiments to quantify allosteric effects on radioligand dissociationTrends in Pharmacological Sciences, 1996
- Allosteric Effects of the Alkane-bis-ammonium Compound W84 and of Tacrine on [3H]Pirenzepine Binding at M1-Receptors in Rat Cerebral CortexBasic & Clinical Pharmacology & Toxicology, 1994
- Protection by Alcuronium of Muscarinic Receptors Against Chemical Inactivation and Location of the Allosteric Binding Site for AlcuroniumJournal of Neurochemistry, 1994
- Muscarinic Acetylcholine ReceptorsPublished by Springer Nature ,1992
- Allosteric regulation of cloned m1–m5 muscarinic receptor subtypesBiochemical Pharmacology, 1991
- Allosteric antagonists of the muscarinic acetylcholine receptorBiochemical Pharmacology, 1991
- ‘Inverse agonists’, cooperativity and drug action at benzodiazepine receptorsTrends in Pharmacological Sciences, 1986
- THE EFFECTS OF IONS ON THE BINDING OF AGONISTS AND ANTAGONISTS TO MUSCARINIC RECEPTORSBritish Journal of Pharmacology, 1979